• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACKR3/CXCR7 趋化因子受体的功能:被感知与被忽视的。

Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.

机构信息

Institute of Anatomy, University of Leipzig, Medical Faculty, Leipzig, Germany.

Institute of Anatomy, University of Leipzig, Medical Faculty, Leipzig, Germany

出版信息

Mol Pharmacol. 2020 Nov;98(5):577-585. doi: 10.1124/molpharm.120.000056. Epub 2020 Sep 3.

DOI:10.1124/molpharm.120.000056
PMID:32883765
Abstract

The CXCL12 system is central to the development of many organs and is further crucially engaged in pathophysiological processes underlying cancer, inflammation, and cardiovascular disorders. This disease-associated role presently focuses major interest on the two CXCL12 receptors, CXCR4 and atypical chemokine receptor 3 (ACKR3)/CXCR7, as promising therapeutic targets. Major obstacles in these ongoing efforts are confusing reports on the differential use of either ACKR3/CXCR7 and/or CXCR4 across various cells as well as on the specific function(s) of ACKR3/CXCR7. Although basically no doubts remain that CXCR4 represents a classic chemokine receptor, functions assigned to ACKR3/CXCR7 range from those of a strictly silent scavenger receptor eventually modulating CXCR4 signaling to an active and independent signaling receptor. In this review, we depict a thorough analysis of our present knowledge on different modes of organization and functions of the cellular CXCL12 system. We further highlight the potential role of ACKR3/CXCR7 as a "crosslinker" of different receptor systems. Finally, we discuss mechanisms with the potency to impinge on the cellular organization of the CXCL12 system and hence might represent additional future therapeutic targets. SIGNIFICANCE STATEMENT: Delineating the recognized functions of atypical chemokine receptor 3 and CXCR4 in CXCL12 signaling is central to the more detailed understanding of the role of the CXCL12 system in health and disease and will help to guide future research efforts.

摘要

CXCL12 系统是许多器官发育的核心,并且在癌症、炎症和心血管疾病的病理生理过程中起着至关重要的作用。这种与疾病相关的作用目前主要集中在两个 CXCL12 受体,即 CXCR4 和非典型趋化因子受体 3(ACKR3)/CXCR7 上,它们是很有前途的治疗靶点。在这些正在进行的努力中,主要的障碍是对 ACKR3/CXCR7 和/或 CXCR4 在各种细胞中的不同用途的混淆报告,以及对 ACKR3/CXCR7 的特定功能的混淆报告。尽管基本上没有疑问认为 CXCR4 代表了一种经典的趋化因子受体,但分配给 ACKR3/CXCR7 的功能从严格沉默的清道夫受体的功能,最终调节 CXCR4 信号,到积极和独立的信号受体的功能。在这篇综述中,我们详细分析了我们目前对细胞 CXCL12 系统不同组织方式和功能的认识。我们进一步强调了 ACKR3/CXCR7 作为不同受体系统的“交联器”的潜在作用。最后,我们讨论了可能影响 CXCL12 系统细胞组织的机制,因此可能代表了额外的未来治疗靶点。

意义陈述

阐明非典型趋化因子受体 3 和 CXCR4 在 CXCL12 信号中的已知功能是更详细地了解 CXCL12 系统在健康和疾病中的作用的核心,这将有助于指导未来的研究工作。

相似文献

1
Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.ACKR3/CXCR7 趋化因子受体的功能:被感知与被忽视的。
Mol Pharmacol. 2020 Nov;98(5):577-585. doi: 10.1124/molpharm.120.000056. Epub 2020 Sep 3.
2
The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.趋化因子受体 ACKR3/CXCR7 在以病毒相关癌症为重点的癌症中对 CXCL12 介导的作用的相关性。
Cytokine Growth Factor Rev. 2014 Jun;25(3):307-16. doi: 10.1016/j.cytogfr.2014.04.006. Epub 2014 May 9.
3
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.CXCL12-CXCR4/CXCR7 轴在结直肠癌中的作用:临床前和临床研究中的治疗靶点。
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.
4
Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.非典型趋化因子受体3(ACKR3/CXCR7)与其趋化因子配体CXCL11和CXCL12相互作用的突变分析
J Biol Chem. 2017 Jan 6;292(1):31-42. doi: 10.1074/jbc.M116.762252. Epub 2016 Nov 14.
5
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.趋化因子受体 3(ACKR3)在心血管疾病中的新兴作用。
Front Endocrinol (Lausanne). 2022 Jun 29;13:906586. doi: 10.3389/fendo.2022.906586. eCollection 2022.
6
CXCR7 as a novel therapeutic target for advanced prostate cancer.CXCR7 作为晚期前列腺癌的新型治疗靶点。
Oncogene. 2023 Mar;42(11):785-792. doi: 10.1038/s41388-023-02597-7. Epub 2023 Feb 9.
7
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.N-端修饰的 CXCL12 趋化因子在 CXCR4 和 ACKR3 受体上的差异活性和选择性。
J Leukoc Biol. 2020 Jun;107(6):1123-1135. doi: 10.1002/JLB.2MA0320-383RR. Epub 2020 May 6.
8
The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.基质细胞衍生因子-1/CXCL12 系统的特点:在某些细胞中,趋化因子受体 4 和 7 独唱,而在其他细胞中,它们则二重唱。
Cell Tissue Res. 2014 Feb;355(2):239-53. doi: 10.1007/s00441-013-1747-y. Epub 2013 Nov 29.
9
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function.ACKR3激动作用诱导与趋化因子受体CXCR4形成异源二聚体并减弱血小板功能。
Eur J Clin Invest. 2025 Jan;55(1):e14327. doi: 10.1111/eci.14327. Epub 2024 Oct 7.
10
Regulation of the chemokine receptors CXCR4 and ACKR3 by receptor activity-modifying proteins.趋化因子受体CXCR4和ACKR3受受体活性调节蛋白的调控。
J Biol Chem. 2025 Jan;301(1):108055. doi: 10.1016/j.jbc.2024.108055. Epub 2024 Dec 9.

引用本文的文献

1
CXCL12 Engages Cortical Inhibitory Neurons to Enhance Dendritic Spine Plasticity and Structured Network Activity.CXCL12 作用于皮质抑制性神经元以增强树突棘可塑性和结构化网络活动。
J Neurosci. 2025 Jun 11;45(24):e2213242025. doi: 10.1523/JNEUROSCI.2213-24.2025.
2
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.反向激动纳米抗体揭示非典型趋化因子受体的组成性活性
bioRxiv. 2024 Nov 4:2024.11.04.621790. doi: 10.1101/2024.11.04.621790.
3
Evaluating CXCL12 for Effects on Reactive Gene Expression in Primary Astrocytes.
评估 CXCL12 对原代星形胶质细胞中反应性基因表达的影响。
J Mol Neurosci. 2024 May 28;74(2):57. doi: 10.1007/s12031-024-02231-5.
4
Atypical chemokine receptors in the immune system.免疫系统中的非典型趋化因子受体
Nat Rev Immunol. 2024 Oct;24(10):753-769. doi: 10.1038/s41577-024-01025-5. Epub 2024 May 7.
5
Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates.生殖细胞肿瘤中CXCR4 / CXCR7轴的分子特征及其使用纳米抗体-药物偶联物的靶向性
Exp Hematol Oncol. 2023 Nov 23;12(1):96. doi: 10.1186/s40164-023-00460-9.
6
Targeting neuro-immune systems to achieve cardiac tissue repair following myocardial infarction: A review of therapeutic approaches from in-vivo preclinical to clinical studies.针对心肌梗死后的心脏组织修复的神经免疫调节策略:从体内临床前研究到临床试验的治疗方法综述。
Pharmacol Ther. 2023 May;245:108397. doi: 10.1016/j.pharmthera.2023.108397. Epub 2023 Mar 28.
7
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.趋化因子 CXCL11 和 CXCL12 在人类肿瘤细胞中的相互作用。
BMC Cancer. 2022 Dec 20;22(1):1335. doi: 10.1186/s12885-022-10451-4.
8
Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells.CXCR4/ACKR3 与 EGFR 信号在乳腺癌细胞中的串扰。
Int J Mol Sci. 2022 Oct 6;23(19):11887. doi: 10.3390/ijms231911887.
9
Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias.非典型趋化因子受体 3 的结构揭示了其混杂性和信号偏向的基础。
Sci Adv. 2022 Jul 15;8(28):eabn8063. doi: 10.1126/sciadv.abn8063. Epub 2022 Jul 13.
10
Selective Elimination of Senescent Fibroblasts by Targeting the Cell Surface Protein ACKR3.通过靶向细胞表面蛋白 ACKR3 选择性消除衰老成纤维细胞。
Int J Mol Sci. 2022 Jun 10;23(12):6531. doi: 10.3390/ijms23126531.